1-20 of 29
Authors: Kathleen Schmainda
Journal Article
NIMG-64. SURVIVAL IMPLICATIONS OF POSTOPERATIVE RESTRICTED DIFFUSION IN HIGH-GRADE GLIOMA AND LIMITATIONS OF INTRAOPERATIVE MRI DETECTION Free
Neuro-Oncology, Volume 26, Issue Supplement_8, November 2024, Page viii210, https://doi.org/10.1093/neuonc/noae165.0828
Published: 11 November 2024
Journal Article
NIMG-09. APPLICATION OF FRACTIONAL TUMOR BURDEN MAPPING TO MONITOR GLIOBLASTOMA PROGRESSION IN THE PHASE 1 TRIAL OF GALLIUM MALTOLATE Free
Neuro-Oncology, Volume 25, Issue Supplement_5, November 2023, Page v186, https://doi.org/10.1093/neuonc/noad179.0705
Published: 10 November 2023
Journal Article
NIMG-29. ADVANCED MRI BIOMARKERS PREDICT EARLY RESPONSE TO TUMOR TREATING FIELDS IN GLIOBLASTOMA Free
Neuro-Oncology, Volume 25, Issue Supplement_5, November 2023, Page v191, https://doi.org/10.1093/neuonc/noad179.0725
Published: 10 November 2023
Journal Article
CTNI-57. PRELIMINARY RESULTS OF A PHASE 1 TRIAL OF ORAL GALLIUM MALTOLATE IN RECURRENT GLIOBLASTOMA Free
Neuro-Oncology, Volume 25, Issue Supplement_5, November 2023, Page v89, https://doi.org/10.1093/neuonc/noad179.0339
Published: 10 November 2023
Journal Article
BIOM-51. IDENTIFICATION OF A LOW-FLIP ANGLE BASED CBV THRESHOLD FOR FRACTIONAL TUMOR BURDEN (FTB) MAPPING IN RECURRENT GLIOBLASTOMA Free
Neuro-Oncology, Volume 25, Issue Supplement_5, November 2023, Pages v15–v16, https://doi.org/10.1093/neuonc/noad179.0062
Published: 10 November 2023
Journal Article
IMG-10. MAGNETIC RESONANCE FUNCTIONAL IMAGING BIOMARKER FOR DISTINGUISHING HIGH GRADE FROM LOW GRADE PEDIATRIC BRAIN TUMORS Open Access
Neuro-Oncology, Volume 25, Issue Supplement_1, June 2023, Pages i48–i49, https://doi.org/10.1093/neuonc/noad073.187
Published: 12 June 2023
Journal Article
NIMG-36. MR PERFUSION IS A BETTER PREDICTOR OF TUMOR RECURRENCE AND TREATMENT RESPONSE THAN STANDARD MRI IN SOME OLIGODENDROGLIOMA PATIENTS Free
Neuro-Oncology, Volume 24, Issue Supplement_7, November 2022, Page vii171, https://doi.org/10.1093/neuonc/noac209.654
Published: 14 November 2022
Journal Article
NIMG-12. DSC-MRI PERFUSION IMAGING IN UNTREATED BRAIN METASTASES USING THE CONSENSUS ACQUISITION PROTOCOL: A MULTI-SITE BENCHMARK STUDY Free
Neuro-Oncology, Volume 24, Issue Supplement_7, November 2022, Pages vii163–vii164, https://doi.org/10.1093/neuonc/noac209.630
Published: 14 November 2022
Journal Article
NIMG-44. DSC-MRI FRACTIONAL TUMOR BURDEN VOLUME PREDICTS OVERALL SURVIVAL IN UNMETHYLATED NEWLY DIAGNOSED HIGH GRADE GLIOMA Free
Neuro-Oncology, Volume 24, Issue Supplement_7, November 2022, Page vii173, https://doi.org/10.1093/neuonc/noac209.662
Published: 14 November 2022
Journal Article
EXTH-16. THE ORAL IRON-MIMETIC GALLIUM MALTOLATE SUPPRESSES TREATMENT-RESISTANT GLIOBLASTOMA – IN VIVO VALIDATION Free
Neuro-Oncology, Volume 24, Issue Supplement_7, November 2022, Page vii212, https://doi.org/10.1093/neuonc/noac209.815
Published: 14 November 2022
Journal Article
BIOM-44. MAGNETIC RESONANCE IMAGING MAPPING OF BRAIN TUMOR BURDEN TO EVALUATE RESPONSE TO PULSED LOW-DOSE-RATE RADIOTHERAPY FOLLOWING RESECTION OF GLIOBLASTOMA MULTIFORME: A 4-PATIENT CASE SERIES Free
Neuro-Oncology, Volume 24, Issue Supplement_7, November 2022, Page vii14, https://doi.org/10.1093/neuonc/noac209.054
Published: 14 November 2022
Journal Article
NIMG-54. LOW FRACTIONAL TUMOR BURDEN VOLUME OBTAINED FROM PERFUSION MRI REVEALS SIGNIFICANT SURVIVAL BENEFIT IN MGMT UNMETHYLATED GLIOBLASTOMA Free
Neuro-Oncology, Volume 24, Issue Supplement_7, November 2022, Page vii176, https://doi.org/10.1093/neuonc/noac209.672
Published: 14 November 2022
Journal Article
TMOD-25. IN VIVO MODEL OF TREATMENT-RESISTANT GLIOBLASTOMA HIGHLIGHTS SEX DIFFERENCES IN SURVIVAL Free
Neuro-Oncology, Volume 22, Issue Supplement_2, November 2020, Page ii233, https://doi.org/10.1093/neuonc/noaa215.975
Published: 09 November 2020
Journal Article
NIMG-28. VALIDATION OF SINGLE-DOSE DSC-MRI PROTOCOLS FOR ROBUST PERFUSION ASSESSMENT IN BRAIN TUMORS Free
Neuro-Oncology, Volume 21, Issue Supplement_6, November 2019, Page vi167, https://doi.org/10.1093/neuonc/noz175.699
Published: 11 November 2019
Journal Article
THER-12. NOVEL IRON-TARGETED THERAPY IS HIGHLY EFFECTIVE IN TREATMENT-RESISTANT HIGH-GRADE GLIOMA IN VIVO Free
Neuro-Oncology, Volume 21, Issue Supplement_2, April 2019, Page ii116, https://doi.org/10.1093/neuonc/noz036.219
Published: 23 April 2019
Journal Article
HGG-05. GALLIUM MALTOLATE AS TREATMENT IN PEDIATRIC GLIOMA Free
Neuro-Oncology, Volume 21, Issue Supplement_2, April 2019, Page ii87, https://doi.org/10.1093/neuonc/noz036.099
Published: 23 April 2019
Journal Article
EXTH-48. ORAL GALLIUM MALTOLATE IMPAIRS TUMOR GROWTH AND EXTENDS DISEASE-SPECIFIC SURVIVAL IN A XENOGRAFT MODEL OF RECURRENT GBM Free
Neuro-Oncology, Volume 20, Issue suppl_6, November 2018, Page vi95, https://doi.org/10.1093/neuonc/noy148.396
Published: 05 November 2018
Journal Article
HGG-14. IRRADIATION OF PEDIATRIC GLIOBLASTOMA CELLS INDUCES DOWNREGULATION OF TUMOR SUPPRESSOR MICRORNA GENES AND UPREGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF) Free
Neuro-Oncology, Volume 20, Issue suppl_2, June 2018, Page i91, https://doi.org/10.1093/neuonc/noy059.286
Published: 22 June 2018
Journal Article
HGG-01. A COMBINED PERFUSION AND DIFFUSION MRI BIOMARKER TO DISTINGUISH PEDIATRIC GLIOMA GRADE Free
Neuro-Oncology, Volume 19, Issue suppl_4, June 2017, Page iv22, https://doi.org/10.1093/neuonc/nox083.090
Published: 31 May 2017
Journal Article
ATPS-02CONTINUOUS ADMINISTRATION OF THE NOVEL IRON-MIMETIC GALLIUM MALTOLATE INHIBITS GLIOMA GROWTH IN VITRO AND IN VIVO Free
Neuro-Oncology, Volume 17, Issue suppl_5, November 2015, Page v18, https://doi.org/10.1093/neuonc/nov204.02
Published: 09 November 2015
